Research Article
Tuberculosis Treatment Outcome in Patients with TB-HIV Coinfection in Kuala Lumpur, Malaysia
Table 2
Clinical characteristics of patients with TB-HIV coinfection (total patients, n = 235).
| | Clinical characteristics | n (%) |
| | DM | | Yes | 9 (3.8) | | No | 226 (96.2) |
| | Smoking status | | Yes | 114 (48.5) | | No | 121 (51.5) |
| | BCG scar | | Present | 213 (90.6) | | Absent | 22 (9.4) |
| | ART | | Yes | 92 (39.1) | | No | 143 (60.9) |
| | Type of TB | | Pulmonary | 174 (74) | | Extrapulmonary | 61 (26) |
| | TB case category | | New case | 199 (84.7) | | Relapse | 25 (10.6) | | Return after lost to follow-up | 11 (4.7) |
| | CXR presentation upon diagnosis | | No/minimal lesion | 159 (67.7) | | Advanced | 70 (29.8) | | Not performed | 6 (2.6) |
| | Sputum smear upon diagnosis | | Positive | 93 (39.6) | | Negative | 119 (50.6) | | Not performed | 23 (9.8) |
| | Sputum culture upon diagnosis | | Positive | 19 (8.1) | | Negative | 149 (63.4) | | Not performed | 67 (28.5) |
| | DOTS status | | Yes | 155 (66) | | No | 80 (34) |
| | Duration of TB treatment (months) | | <6 | 103 (43.8) | | 6–12 | 113 (48.1) | | ≥12 | 19 (8.1) |
| | TB treatment outcome | | Cured | 47 (20) | | Completed treatment | 89 (37.9) | | Died | 72 (30.6) | | Failure | 22 (9.4) | | Lost to follow-up | 5 (2.1) |
|
|
